Pathophysiology of status epilepticus.
Walker MC.
Neurosci Lett. 2018 Feb 22;667:84-91. doi: 10.1016/j.neulet.2016.12.044. Epub 2016 Dec 20.
Status Epilepticus.
Seinfeld S, Goodkin HP, Shinnar S.
Cold Spring Harb Perspect Med. 2016 Mar 1;6(3):a022830. doi: 10.1101/cshperspect.a022830.
Chronic epileptogenic cellular alterations in the limbic system after status epilepticus.
Coulter DA.
Epilepsia. 1999;40 Suppl 1:S23-33; discussion S40-1. doi: 10.1111/j.1528-1157.1999.tb00875.x.
New-onset Refractory Status Epilepticus Involving the Limbic System, Spinal Cord, and Peripheral Nerves.
Daida K, Nishioka K, Takanashi M, Kobayashi M, Yoshikawa K, Kusunoki S, Yokoyama K, Hattori N.
Intern Med. 2020 Jan 15;59(2):267-270. doi: 10.2169/internalmedicine.3510-19. Epub 2019 Sep 11.
Antagomirs and microRNA in status epilepticus.
Henshall DC.
Epilepsia. 2013 Sep;54 Suppl 6(0 6):17-9. doi: 10.1111/epi.12267.
Reclusive chandeliers: Functional isolation of dentate axo-axonic cells after experimental status epilepticus.
Proddutur A, Nguyen S, Yeh CW, Gupta A, Santhakumar V.
Prog Neurobiol. 2023 Dec;231:102542. doi: 10.1016/j.pneurobio.2023.102542. Epub 2023 Oct 26.
Epileptiform activity in the limbic system.
Oliveira MS, Pacheco LF, Mello CF, Cavalheiro EA, Garrido-Sanabria ER.
Front Biosci (Schol Ed). 2011 Jan 1;3(2):565-93. doi: 10.2741/s172.
Repurposing of cholesterol-lowering agents in status epilepticus: A neuroprotective effect of simvastatin.
Hanin A, Roussel D, Lecas S, Baudin P, Navarro V.
Epilepsy Behav. 2023 Apr;141:109133. doi: 10.1016/j.yebeh.2023.109133. Epub 2023 Feb 20.
Rearranging receptors.
Brooks-Kayal AR.
Epilepsia. 2005;46 Suppl 7:29-38. doi: 10.1111/j.1528-1167.2005.00301.x.
Delayed sclerosis, neuroprotection, and limbic epileptogenesis after status epilepticus in the rat.
Ebert U, Brandt C, Löscher W.
Epilepsia. 2002;43 Suppl 5:86-95. doi: 10.1046/j.1528-1157.43.s.5.39.x.
